Northwestern University scientists have developed a new method for testing for SARS-CoV-2 (the virus that causes COVID-19) antibodies, requiring only a single drop of blood collected from a simple finger prick.
Investigators at Northwestern University and Shirley Ryan AbilityLab in Chicago have developed a novel wearable device and are creating a set of data algorithms specifically tailored to catch early signs and symptoms associated with COVID-19.
Northwestern Medicine experts discuss the phenomenon of “caution fatigue,” where people may find it difficult to stay on high-risk alert after weeks of social distancing and isolation to stop the spread of COVID-19.
There are variety of ways improve care delivery, interpret new information, and maintain clinical trials and experiments in the face of the COVID-19 pandemic, according to recent editorials published by Feinberg faculty.
Students are conducting telehealth visits and reaching out to patients at high risk of complications from COVID-19, part of the transition of the Education Centered Medical Home to virtual care.
The Center for Community Health’s Alliance for Research in Chicagoland Communities (ARCC) hosted a virtual discussion for participants to share experiences, strategies and challenges about engaging and supporting community-engaged research partners during the COVID-19 pandemic.
Many individuals in the highest risk category for COVID-19 because of multiple chronic health conditions didn’t think the disease would affect them and reported not changing their behavior at the beginning of Chicago’s outbreak, according to a new study.
Northwestern Medicine cardiovascular experts discuss how racial disparities, including lower socioeconomic status and pre-existing cardiovascular conditions, can lead African-Americans to be at higher risk for contracting and dying from COVID-19.
First-year medical student Tazim Merchant co-organized the “Students Supporting the Community During COVID-19” project, a volunteer effort among medical students and graduate students at Feinberg that support healthcare workers, older community members and working parents in Chicago during the COVID-19 pandemic.
Northwestern Medicine has enrolled its first participants in a new international clinical drug trial for COVID-19, testing remdesivir, a novel anti-viral drug developed to treat Ebola, and which has also shown antiviral activity in coronaviruses.